These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8926069)

  • 21. 3-Sulfogalactosyl-dependent adhesion of
    Al-Saedi F; Vaz DP; Stones DH; Krachler AM
    J Biol Chem; 2017 Dec; 292(48):19792-19803. PubMed ID: 28982977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Campylobacter upsaliensis gastroenteritis in childhood.
    Jimenez SG; Heine RG; Ward PB; Robins-Browne RM
    Pediatr Infect Dis J; 1999 Nov; 18(11):988-92. PubMed ID: 10571436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do they stick together? Bacterial adhesins implicated in the binding of bacteria to the human gastrointestinal mucins.
    Ringot-Destrez B; Kalach N; Mihalache A; Gosset P; Michalski JC; Léonard R; Robbe-Masselot C
    Biochem Soc Trans; 2017 Apr; 45(2):389-399. PubMed ID: 28408479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of attachment of Escherichia coli RDEC-1 to intestinal microvillus membranes by rabbit ileal mucus and mucin in vitro.
    Drumm B; Roberton AM; Sherman PM
    Infect Immun; 1988 Sep; 56(9):2437-42. PubMed ID: 3045000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin.
    Sajjan SU; Forstner JF
    Infect Immun; 1990 Apr; 58(4):860-7. PubMed ID: 1969394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants.
    Tu QV; McGuckin MA; Mendz GL
    J Med Microbiol; 2008 Jul; 57(Pt 7):795-802. PubMed ID: 18566135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic heterogeneity and O-antigenic diversity of Campylobacter upsaliensis and Campylobacter helveticus strains isolated from dogs and cats in Germany.
    Moser I; Rieksneuwöhner B; Lentzsch P; Schwerk P; Wieler LH
    J Clin Microbiol; 2001 Jul; 39(7):2548-57. PubMed ID: 11427567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purified chicken intestinal mucin attenuates Campylobacter jejuni pathogenicity in vitro.
    Alemka A; Whelan S; Gough R; Clyne M; Gallagher ME; Carrington SD; Bourke B
    J Med Microbiol; 2010 Aug; 59(Pt 8):898-903. PubMed ID: 20466838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adapted in vitro assay to assess Campylobacter jejuni interaction with intestinal epithelial cells: Taking into stimulation with TNFα.
    Rodrigues RC; Pocheron AL; Cappelier JM; Tresse O; Haddad N
    J Microbiol Methods; 2018 Jun; 149():67-72. PubMed ID: 29729311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and description of "Campylobacter upsaliensis" isolated from human feces.
    Goossens H; Pot B; Vlaes L; Van den Borre C; Van den Abbeele R; Van Naelten C; Levy J; Cogniau H; Marbehant P; Verhoef J
    J Clin Microbiol; 1990 May; 28(5):1039-46. PubMed ID: 2351720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods to Assess the Direct Interaction of C. jejuni with Mucins.
    Clyne M; Duggan G; Naughton J; Bourke B
    Methods Mol Biol; 2017; 1512():107-115. PubMed ID: 27885602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells.
    McSweegan E; Burr DH; Walker RI
    Infect Immun; 1987 Jun; 55(6):1431-5. PubMed ID: 3570473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States.
    Patton CM; Shaffer N; Edmonds P; Barrett TJ; Lambert MA; Baker C; Perlman DM; Brenner DJ
    J Clin Microbiol; 1989 Jan; 27(1):66-73. PubMed ID: 2913038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum.
    Bitzan MM; Gold BD; Philpott DJ; Huesca M; Sherman PM; Karch H; Lissner R; Lingwood CA; Karmali MA
    J Infect Dis; 1998 Apr; 177(4):955-61. PubMed ID: 9534968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells.
    Kim Y; Kim SH; Whang KY; Kim YJ; Oh S
    J Microbiol Biotechnol; 2008 Jul; 18(7):1278-85. PubMed ID: 18667857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa cells and T lymphocytes.
    Trott S; Bauer R; Knackmuss HJ; Stolz A
    Microbiology (Reading); 2001 Mar; 147(Pt 3):1815-1824. PubMed ID: 11238981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro.
    Gold BD; Huesca M; Sherman PM; Lingwood CA
    Infect Immun; 1993 Jun; 61(6):2632-8. PubMed ID: 8500901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches.
    Lindén SK; Wickström C; Lindell G; Gilshenan K; Carlstedt I
    Helicobacter; 2008 Apr; 13(2):81-93. PubMed ID: 18321298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direction of neutrophil movements by Campylobacter-infected intestinal epithelium.
    Murphy H; Cogan T; Humphrey T
    Microbes Infect; 2011 Jan; 13(1):42-8. PubMed ID: 20934530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basis of the superiority of cefoperazone amphotericin teicoplanin for isolating Campylobacter upsaliensis from stools.
    Byrne C; Doherty D; Mooney A; Byrne M; Woodward D; Johnson W; Rodgers F; Bourke B
    J Clin Microbiol; 2001 Jul; 39(7):2713-6. PubMed ID: 11427603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.